BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 26275479)

  • 1. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
    Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
    Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella-zoster virus-specific, cell-mediated immunity with interferon-gamma release assay after vaccination of college students with no or intermediate IgG antibody response.
    Terada K; Itoh Y; Fujii A; Kitagawa S; Ogita S; Ouchi K
    J Med Virol; 2015 Feb; 87(2):350-6. PubMed ID: 25080078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and humoral immunity after vaccination or natural mumps infection.
    Terada K; Hagihara K; Oishi T; Miyata I; Akaike H; Ogita S; Ohno N; Ouchi K
    Pediatr Int; 2017 Aug; 59(8):885-890. PubMed ID: 28432833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of measles-rubella vaccination for mothers in early puerperal phase.
    Hisano M; Kato T; Inoue E; Sago H; Yamaguchi K
    Vaccine; 2016 Feb; 34(9):1208-14. PubMed ID: 26801065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts.
    Lambert ND; Haralambieva IH; Ovsyannikova IG; Larrabee BR; Pankratz VS; Poland GA
    Immunol Res; 2014 Jan; 58(1):1-8. PubMed ID: 24375276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
    Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
    J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
    Rossier E; Phipps PH; Polley JR; Webb T
    Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rubella vaccination: antibody persistence for 14-17 years and immune status of women without and with a history of vaccination].
    Enders G; Nickerl U
    Immun Infekt; 1988 Apr; 16(2):58-64. PubMed ID: 3391631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB; Kao CL; Lee CY
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigations on the dependency of hemagglutination inhibition titers against rubella virus on the number and quality of antibody molecules (author's transl)].
    Hoppe G
    Zentralbl Bakteriol A; 1981; 249(2):143-51. PubMed ID: 7269848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of interleukin-2 receptor alpha and CD45RO antigen on T lymphocytes cultured with rubella virus antigen, compared with humoral immunity in rubella vaccinees.
    Toyoda M; Ihara T; Nakano T; Ito M; Kamiya H
    Vaccine; 1999 Apr; 17(15-16):2051-8. PubMed ID: 10217606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to determine protective immunity in the post-vaccine era.
    Charlton CL; Lai FY; Dover DC
    Hum Vaccin Immunother; 2016 Apr; 12(4):903-6. PubMed ID: 26811063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rubella immunization with HPV77DE5 and RA 27/3 vaccines of 11 to 16-year-old girls: studies of antibody formation and antibody resistance after 4 and 8 years].
    Gitmans U; Enders G; Glück H; Harm B; Lindemann L
    Immun Infekt; 1983 May; 11(3):79-90. PubMed ID: 6676174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
    Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
    J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center.
    Okuda M; Yamanaka M; Takahashi T; Ishikawa H; Endoh M; Hirahara F
    J Obstet Gynaecol Res; 2008 Apr; 34(2):168-73. PubMed ID: 18412777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.
    Coté TR; Sivertson D; Horan JM; Lindegren ML; Dwyer DM
    Public Health Rep; 1993; 108(4):431-5. PubMed ID: 8341775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubella immunity measured by hemagglutination inhibition and enzyme-linked immunosorbent assay.
    Hornstein L; Swartz TA; Heimann M
    Isr J Med Sci; 1985 Aug; 21(8):666-9. PubMed ID: 4044233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and immunization of rubella-susceptible women. Experience in a large, prepaid medical group.
    Shlian DM
    JAMA; 1978 Aug; 240(7):662-3. PubMed ID: 671687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.